Freenome, Inc.
Ownership
Ownership Structure
Who owns Freenome, Inc. (FRNM)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 63.7% of the shares are freely tradable; institutional investors hold 23.3%.
Largest Shareholders
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| T. Rowe Price Small-Cap Stock | 1.06 | 1,133,948 | +0.0 | 07/31/2026 |
| ARK Genomic Revolution ETF | 0.71 | 764,341 | -0.3 | 08/31/2026 |
| T. Rowe Price Instl Small-Cap Stock | 0.57 | 615,045 | +0.0 | 07/31/2026 |
| T. Rowe Price Health Sciences | 0.41 | 438,178 | +0.0 | 07/31/2026 |
| Fidelity Growth Company Fund | 0.37 | 397,340 | +0.0 | 07/31/2026 |
| abrdn Healthcare Opportunities | 0.37 | 395,392 | +0.0 | 07/31/2026 |
| Fidelity Select Medical Tech and Devcs | 0.29 | 316,757 | +0.0 | 07/31/2026 |
| abrdn World Healthcare | 0.24 | 256,477 | +0.0 | 07/31/2026 |
| T. Rowe Price Global Stock | 0.22 | 231,506 | +0.0 | 07/31/2026 |
| Fidelity Series Growth Company | 0.07 | 79,952 | +0.0 | 07/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Elliott Aaron Matthew | Chief Executive Officer | 345,976 | 5,535,616 $ | Sep 2, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 2, 2026 | Elliott Aaron Matthew | Chief Executive Officer | Other | 71,920 | 15.25 | 1,096,780 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.